Physician profile
Brian J Mitchell
NPI 1942491196
$8,947.08
in general payments reported to CMS, 2019-2025
17 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,038 · 2020: $1,230 · 2021: $838 · 2022: $3,405 · 2023: $771 · 2024: $1,416 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,436.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,721.28 | 2022-2024 | Nuvent, Propel, Pteye Parathyroid Detection System |
| Inspire Medical Systems, INC. | $2,663.98 | 2019-2025 | Inspire |
| Kls-Martin L.P. | $757.34 | 2023-2024 | |
| Livanova USA, INC. | $428.57 | 2019-2022 | |
| Stryker Corporation | $339.20 | 2019-2025 | Vsp System, Vsp Cranial, Na, Adherus Autospray Et Dural Sealant |
| Medtronic USA, INC. | $262.49 | 2019-2020 | |
| Aerin Medical INC. | $228.49 | 2023-2024 | |
| Teleflex LLC | $137.28 | 2024 | Urolift |
| Ascendis Pharma Endocrinology INC | $83.19 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $78.36 | 2019 | |
| Glaxosmithkline, LLC. | $51.38 | 2021 | |
| Itamar Medical INC | $40.72 | 2023 | Watchpatone |
| Regeneron Healthcare Solutions, INC. | $40.19 | 2024 | Dupixent |
| Genzyme Corporation | $32.50 | 2019-2023 | |
| Baxter Healthcare | $31.84 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $29.61 | 2025 | Tula |
| Alk-Abello, INC | $20.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.